We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-6.99%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$309M
AUM Growth
+$9.64M
Cap. Flow
+$29.4M
Cap. Flow %
9.51%
Top 10 Hldgs %
36.34%
Holding
93
New
15
Increased
35
Reduced
30
Closed
7

Top Buys

Rank Stock Value
1
EVHC
Envision Healthcare Holdings Inc
EVHC
+$7.87M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$6.46M
3
ELV icon
Elevance Health
ELV
+$5.1M
4
WBA
Walgreens Boots Alliance
WBA
+$4.56M
5
BSX icon
Boston Scientific
BSX
+$4.4M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$4.58M
2
ABBV icon
AbbVie
ABBV
+$4.49M
3
MDT icon
Medtronic
MDT
+$4.43M
4
ZBH icon
Zimmer Biomet
ZBH
+$3.96M
5
ABT icon
Abbott
ABT
+$3.76M

Sector Composition

Rank Sector Weight
1 Healthcare 83.88%
2 Financials 3.47%
3 Industrials 1.36%
4 Technology 0.14%
5 Consumer Staples 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
51
DELISTED
Celgene Corp
CELG
$1.43M 0.46%
14,280
-12,400
-46% -$1.28M
CNMD icon
52
CONMED
CNMD
$1.39B
$1.18M 0.38%
+28,090
New +$1.1M
PEN icon
53
Penumbra
PEN
$12.7B
$1.14M 0.37%
+24,700
New +$1.15M
MDVN
54
DELISTED
MEDIVATION, INC.
MDVN
$1.06M 0.34%
23,100
+11,600
+101% +$421K
RAD
55
DELISTED
Rite Aid Corporation
RAD
$995K 0.32%
6,105
-1,253
-17% -$198K
CVS icon
56
CVS Health
CVS
$133B
$882K 0.29%
8,500
-16,400
-66% -$1.59M
ABT icon
57
Abbott
ABT
$183B
$840K 0.27%
20,084
-94,900
-83% -$3.76M
AMGN icon
58
Amgen
AMGN
$208B
$840K 0.27%
+5,600
New +$832K
CRL icon
59
Charles River Laboratories
CRL
$11.2B
$827K 0.27%
10,888
+2,300
+27% +$170K
PARN
60
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$822K 0.27%
385,902
-49,725
-11% -$137K
HUM icon
61
Humana
HUM
$43.7B
$713K 0.23%
3,898
-2,800
-42% -$486K
VRTX icon
62
Vertex Pharmaceuticals
VRTX
$121B
$696K 0.23%
8,750
-9,500
-52% -$859K
GI
63
DELISTED
EndoChoice Holdings, Inc.
GI
$681K 0.22%
130,763
-93,200
-42% -$511K
INCY icon
64
Incyte
INCY
$24.2B
$565K 0.18%
7,800
+2,100
+37% +$157K
MRK icon
65
Merck
MRK
$322B
$535K 0.17%
10,590
-38,147
-78% -$1.87M
AERI
66
DELISTED
Aerie Pharmaceuticals
AERI
$525K 0.17%
+43,200
New +$684K
NBIX icon
67
Neurocrine Biosciences
NBIX
$16.8B
$518K 0.17%
+13,100
New +$520K
TVTY
68
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$517K 0.17%
51,211
– –
ONCE
69
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$516K 0.17%
+17,500
New +$552K
SSRG
70
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
$467K 0.15%
47,319
-21,014
-31% -$197K
PRGO icon
71
Perrigo
PRGO
$1.4B
$461K 0.15%
+3,600
New +$492K
CAH icon
72
Cardinal Health
CAH
$53.9B
$426K 0.14%
5,200
-12,300
-70% -$1M
CSLT
73
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$425K 0.14%
127,604
-314,904
-71% -$1.03M
OCRX
74
DELISTED
Ocera Therapeutics, Inc.
OCRX
$403K 0.13%
137,093
– –
NXTM
75
DELISTED
NxStage Medical Inc.
NXTM
$396K 0.13%
+26,400
New +$442K
1 2
3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Endurant Capital Management held 93 positions worth $309M, up 3.2% from $299M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Endurant Capital Management deployed $29.4M of net new capital in Q1 2016, opening 15 new positions and adding to 35 existing holdings. Its largest new stake was Envision Healthcare Holdings Inc: 119,706 shares worth $7.31M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 89% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Viatris, an estimated $4.58M trimmed.

  • Endurant Capital Management's largest Q1 2016 buy was Envision Healthcare Holdings Inc: 119,706 shares worth $7.31M.
  • Endurant Capital Management added most to HILL-ROM HOLDINGS, INC. in Q1 2016, an estimated $6.46M increase.
  • Endurant Capital Management's biggest Q1 2016 reduction was Viatris, cutting an estimated $4.58M.
  • Endurant Capital Management fully exited BioDelivery Sciences International, Inc. in Q1 2016, selling an estimated $1.33M.
  • Endurant Capital Management's ten largest holdings make up 36% of its $309M portfolio in Q1 2016.
  • Endurant Capital Management opened 15 new positions and closed 7 in Q1 2016.
  • Endurant Capital Management's portfolio value rose 3.2% quarter-over-quarter to $309M.

Based on Endurant Capital Management's 13F filing for Q1 2016, filed 16 May 2016.